Navigation Links
K-V Pharmaceutical Secures Financing Commitments Establishing Path Forward For Specialty Pharmaceutical Business
Date:11/17/2010

p>(24)   delays in returning, or failure to return, certain or many of the Registrant's approved products to the market, including loss of market share as a result of the suspension of shipments, and related costs;

(25)   the ability to sell or license certain assets, and the terms of such transactions;

(26)   the possibility that default on one type or class of the Registrant's indebtedness could result in cross default under, and the acceleration of, its other indebtedness;

(27)   the risks that present or future changes in the Board of Directors or management may lead to an acceleration of the Registrant's bonds or to adverse actions by government agencies or our auditors;

(28)   the risk that even though the price and 30-day average price of the Registrant's Class A common stock and Class B common stock satisfies the quantitative listing standards of the New York Stock Exchange, including with respect to minimum share price and public float, the Registrant can provide no assurance that they will remain at such levels thereafter;

(29)   the risk that BDO will be unable to complete the audit of the Company's financial statements to be included in its annual report for its fiscal year ended March 31, 2010 in order for the Company to meet the extension period granted by the New York Stock Exchange to comply with their listing standards and the subsequent risk that the inability to complete the Form-10-Q's for fiscal year 2011 on a timely basis could impact the timely filing of the fiscal year 2011 Form 10-K.

(30)   the risks detailed from time-to-time in the Registrant's filings with the SEC.

This discussion is not exhaustive, but is designed to highlight important factors that may impact the Registrant's forward-looking statements.  Because the factors referred to above, as well as the statements included elsewhere in this report and in the exhibits hereto, could cause actual r
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015   BioClinica®, Inc ... provider, today announced that it has acquired a ... ® , Inc. (Medici).  The acquisition includes affiliates ... LLC.  Medici also provides a lost-to-follow-up patient locate ... globally.  Together with Medici, BioClinica will ...
(Date:7/6/2015)... BEDFORD, Mass. , July 6, 2015 ... the Company plans to release its financial results for ... 29, 2015, after the market closes.  In conjunction with ... day at 4:30 p.m. Eastern Time. Interested ... (in the United States ) or ...
(Date:7/6/2015)... FARMINGTON, Conn. , July 6, ... a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ... medical need and commercial potential, today announced that ... Series E warrants to purchase 21,917,808 shares of ... purchase 2,191,781 shares of its common stock.  Certain ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5
... 29, 2012 STAAR Surgical Company (NASDAQ: ... implantable lenses for the eye, today announced that it ... the Company,s recent financial results and current business developments ... Company One-on-One Investor Conference will be held on Thursday, ...
... May 29, 2012  Abaxis, Inc. (NasdaqGS: ABAX), a medical ... that Clint Severson, chairman and chief executive officer , ... on Tuesday, June 5, 2012 at 9:00 a.m. ET. ... in New York City. About AbaxisAbaxis ...
Cached Medicine Technology:STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences 2
(Date:7/6/2015)... ... 2015 , ... Acara Partners, a leading business team in ... complimentary educational webinar series for the summer of 2015. Learn ... clients through targeted marketing, sales, digital communications, branding and business development programs. The ...
(Date:7/6/2015)... Virginia (PRWEB) , ... July 06, 2015 , ... ... choose fat-reduction procedures each year for aesthetic reasons, which is why liposuction regularly ... For a particular demographic, however, fat reduction has become more than a way ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Olive Fertility Centre ... UBC 2014-2015 Post Graduate Teaching Award on behalf of the department of Family Practice. ... very exciting field to be practicing in. The technology is changing so rapidly and ...
(Date:7/6/2015)... ... ... doTERRA, the leading global essential oils company, is pleased to announce the ... position as Director of the Hinckley Institute at the University of Utah, a position ... states that he was ready for a new challenge, and out of many potential ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network (CHN) ... and medical professionals to chat with the CHN patient services team and connect ... cancer diagnosis is often the most traumatic experience of a person’s life,” said ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2
... Leaders to Reject Oxygen Funding Reductions,which could ,Jeopardize ... Achieve, Letter Draws Widespread Support Among Home ... Council for Quality,Respiratory Care (CQRC) -- a coalition ... manufacturers who provide care and services to,approximately 650,000 ...
... national No Smoking Day on 12th March by claiming that ... then recent research from the Peninsula Medical School in the ... Extensive research carried out by Dr Iain Lang at the ... psychological wellbeing. Dr Lang and colleagues used a measure of ...
... recycling system: Discarded cellular components, from individual proteins through ... blocks re-used in a different place. The scientific term ... cells, autophagy can also be a form of programmed ... mechanism for complete self-decomposition. , Cancer cells, too, ...
... Philadelphia, PA, March 6, 2008 Surgeons are uniquely ... and to develop innovative solutions to meet those needs. ... lack the know-how to develop their insights into successful ... issue of SURGERY (Volume 143, Number 2, February 2008) ...
... Inc. (OTC Bulletin Board: MLSS), the recognized leader ... month of,February, dentists purchased more units of the ... system for dental,injections, than in any month since ... President of Sales and Marketing at Milestone,stated, "It ...
... Hospital in 25 Years, DENVER, March ... Board: GLOB), an international e-Health, medical,information technology ... has signed an agreement with Mid Coast ... its SafeTrace Tx(R) transfusion,management software. Terms of ...
Cached Medicine News:Health News:Home Oxygen Community Applauds Senator Barbara Mikulski for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicare's Home Oxygen Benefit 2Health News:'Surgery' looks at inventions and innovations by surgeons 2Health News:Milestone Scientific Announces Chicago Dental Society's 143rd Midwinter Meeting Proved Successful 2Health News:Milestone Scientific Announces Chicago Dental Society's 143rd Midwinter Meeting Proved Successful 3Health News:Newest Hospital in New England Signs Agreement With Global Med Technologies(R), Inc. 2Health News:Newest Hospital in New England Signs Agreement With Global Med Technologies(R), Inc. 3
... Wrist Fixator is now available in a ... necessary instrumentation. The surgical technique is printed ... reference. , ,This fixator allows the surgeon ... making multipaner adjustments in the frame via ...
... The WristJack External Fixation System for ... palmar tilt, radial inclination, length and rotation. ... to place the wrist into extension without ... are easily performed in the surgeons office. ...
... slender design contributes to overall low-profile frame ... The Connecting Clamp allows connection of 3.0 ... Uses 3.0 mm Carbon Fiber Rods. The ... to predrill and provide more stability and ...
The DFS MiniFixator is a lightweight, external device for the treatment of small bone fractures and osteotomies....
Medicine Products: